In the New Era of Shamelessness, the company now feels comfortable revealing in one complete list what the shareholders received from Nasrat for our $10 million. As it turns out, 5 of 13 ANDA's were for various forms of phentermine. (Ever heard of fen-phen?) The pending ANDA for Fioricet was apparently never approved. Nothing on the whole list worth more than a few hundred thousand dollars, most of them a fraction of that.
News 
Market Data 
Discover 
AI
